Yatin Suneja
Stock Analyst at Guggenheim
(4.74)
# 212
Out of 5,182 analysts
171
Total ratings
60.9%
Success rate
30.61%
Average return
Main Sectors:
Stocks Rated by Yatin Suneja
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IFRX InflaRx | Reiterates: Buy | $14 | $1.67 | +738.32% | 8 | Apr 21, 2026 | |
| ORKA Oruka Therapeutics | Reiterates: Buy | $125 | $73.99 | +68.94% | 5 | Apr 13, 2026 | |
| NMRA Neumora Therapeutics | Reiterates: Buy | $14 | $2.25 | +522.22% | 4 | Mar 31, 2026 | |
| DBVT DBV Technologies | Reiterates: Buy | $51 | $20.80 | +145.19% | 3 | Mar 27, 2026 | |
| AXSM Axsome Therapeutics | Maintains: Buy | $220 → $245 | $185.00 | +32.43% | 11 | Mar 25, 2026 | |
| CABA Cabaletta Bio | Maintains: Buy | $15 → $16 | $2.86 | +459.44% | 7 | Mar 24, 2026 | |
| IMUX Immunic | Initiates: Buy | $70 | $10.75 | +551.16% | 1 | Mar 24, 2026 | |
| ZBIO Zenas BioPharma | Maintains: Buy | $45 → $55 | $18.01 | +205.39% | 4 | Mar 17, 2026 | |
| ACET Adicet Bio | Maintains: Buy | $128 → $100 | $7.67 | +1,203.78% | 4 | Mar 13, 2026 | |
| DNTH Dianthus Therapeutics | Maintains: Buy | $100 → $200 | $83.67 | +139.03% | 3 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $50 | $39.59 | +26.29% | 1 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $25 | $11.33 | +120.65% | 5 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,160 → $1,120 | $775.03 | +44.51% | 14 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $760 → $800 | $321.92 | +148.51% | 5 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $865 → $975 | $731.77 | +33.24% | 9 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $246 | $183.38 | +34.15% | 4 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $30 | $27.77 | +8.03% | 4 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $44 | $26.99 | +63.02% | 9 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $12.86 | +288.80% | 1 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $32 | $24.02 | +33.22% | 3 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $3.53 | +324.93% | 1 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $100 | $66.11 | +51.26% | 14 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $101 → $150 | $109.87 | +36.52% | 3 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $20 | $16.66 | +20.05% | 4 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $26.27 | +185.50% | 1 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $175 | $128.12 | +36.59% | 6 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $4.40 | +490.91% | 6 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $29 | $19.85 | +46.10% | 1 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $5.30 | +183.02% | 2 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $45 | $30.98 | +45.26% | 3 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 | $22.67 | -11.78% | 6 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.72 | - | 2 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $65 | $68.63 | -5.29% | 1 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $90 | $33.23 | +170.84% | 5 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.06 | - | 3 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $49 | $54.53 | -10.14% | 2 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $55 | $13.47 | +308.31% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.24 | - | 3 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $15.72 | +52.67% | 1 | May 31, 2022 |
InflaRx
Apr 21, 2026
Reiterates: Buy
Price Target: $14
Current: $1.67
Upside: +738.32%
Oruka Therapeutics
Apr 13, 2026
Reiterates: Buy
Price Target: $125
Current: $73.99
Upside: +68.94%
Neumora Therapeutics
Mar 31, 2026
Reiterates: Buy
Price Target: $14
Current: $2.25
Upside: +522.22%
DBV Technologies
Mar 27, 2026
Reiterates: Buy
Price Target: $51
Current: $20.80
Upside: +145.19%
Axsome Therapeutics
Mar 25, 2026
Maintains: Buy
Price Target: $220 → $245
Current: $185.00
Upside: +32.43%
Cabaletta Bio
Mar 24, 2026
Maintains: Buy
Price Target: $15 → $16
Current: $2.86
Upside: +459.44%
Immunic
Mar 24, 2026
Initiates: Buy
Price Target: $70
Current: $10.75
Upside: +551.16%
Zenas BioPharma
Mar 17, 2026
Maintains: Buy
Price Target: $45 → $55
Current: $18.01
Upside: +205.39%
Adicet Bio
Mar 13, 2026
Maintains: Buy
Price Target: $128 → $100
Current: $7.67
Upside: +1,203.78%
Dianthus Therapeutics
Mar 4, 2026
Maintains: Buy
Price Target: $100 → $200
Current: $83.67
Upside: +139.03%
Mar 3, 2026
Maintains: Buy
Price Target: $45 → $50
Current: $39.59
Upside: +26.29%
Feb 27, 2026
Maintains: Buy
Price Target: $20 → $25
Current: $11.33
Upside: +120.65%
Feb 27, 2026
Maintains: Buy
Price Target: $1,160 → $1,120
Current: $775.03
Upside: +44.51%
Feb 10, 2026
Maintains: Buy
Price Target: $760 → $800
Current: $321.92
Upside: +148.51%
Feb 9, 2026
Maintains: Buy
Price Target: $865 → $975
Current: $731.77
Upside: +33.24%
Feb 9, 2026
Maintains: Buy
Price Target: $185 → $246
Current: $183.38
Upside: +34.15%
Feb 9, 2026
Maintains: Buy
Price Target: $28 → $30
Current: $27.77
Upside: +8.03%
Feb 9, 2026
Maintains: Buy
Price Target: $41 → $44
Current: $26.99
Upside: +63.02%
Feb 2, 2026
Initiates: Buy
Price Target: $50
Current: $12.86
Upside: +288.80%
Jan 7, 2026
Maintains: Buy
Price Target: $18 → $32
Current: $24.02
Upside: +33.22%
Dec 19, 2025
Initiates: Buy
Price Target: $15
Current: $3.53
Upside: +324.93%
Nov 5, 2025
Maintains: Buy
Price Target: $90 → $100
Current: $66.11
Upside: +51.26%
Oct 10, 2025
Maintains: Buy
Price Target: $101 → $150
Current: $109.87
Upside: +36.52%
Sep 30, 2025
Maintains: Buy
Price Target: $80 → $20
Current: $16.66
Upside: +20.05%
Aug 18, 2025
Initiates: Buy
Price Target: $75
Current: $26.27
Upside: +185.50%
Aug 1, 2025
Maintains: Buy
Price Target: $165 → $175
Current: $128.12
Upside: +36.59%
Jun 25, 2025
Reiterates: Buy
Price Target: $26
Current: $4.40
Upside: +490.91%
May 9, 2025
Maintains: Buy
Price Target: $32 → $29
Current: $19.85
Upside: +46.10%
Mar 26, 2025
Reiterates: Buy
Price Target: $15
Current: $5.30
Upside: +183.02%
Jan 3, 2025
Upgrades: Buy
Price Target: $45
Current: $30.98
Upside: +45.26%
Jan 3, 2025
Downgrades: Neutral
Price Target: $20
Current: $22.67
Upside: -11.78%
Dec 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.72
Upside: -
Oct 25, 2024
Maintains: Buy
Price Target: $50 → $65
Current: $68.63
Upside: -5.29%
Feb 27, 2024
Maintains: Buy
Price Target: $72 → $90
Current: $33.23
Upside: +170.84%
Jul 17, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.06
Upside: -
Jun 15, 2023
Reiterates: Buy
Price Target: $49
Current: $54.53
Upside: -10.14%
May 18, 2023
Maintains: Buy
Price Target: $52 → $55
Current: $13.47
Upside: +308.31%
Oct 14, 2022
Downgrades: Neutral
Price Target: n/a
Current: $7.24
Upside: -
May 31, 2022
Initiates: Buy
Price Target: $24
Current: $15.72
Upside: +52.67%